Director, R&D Neuroscience Data Science and Digital Health

Johnson & Johnson Innovative Medicine is currently seeking a Director, R&D Neuroscience Data Science and Digital Health with a strong preference for this individual to be located at one of our sites in Cambridge, MA, Titusville, NJ, or La Jolla, CA. (Remote work options within the US may be considered on a case-by-case basis and if approved by the company.)

At Johnson & Johnson,?we believe health is everything. Our strength in healthcare innovation empowers us to build a?world where complex diseases are prevented, treated, and cured,?where treatments are smarter and less invasive, and?solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day. Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world. Our diverse workforce and culture of belonging accelerate innovation to solve the world’s most pressing healthcare challenges.

We know that the success of our business – and our ability to deliver meaningful solutions – depends on how well we understand and meet the diverse needs of the communities we serve. Which is why we foster a culture of inclusion and belonging where all perspectives, abilities and experiences are valued and our people can reach their potential.

At Johnson & Johnson, we all belong.

This outstanding leader, and data scientist will be a member of Neuroscience Data Science and Digital Health's Digital and AI measures team, working to optimize the precision measurement strategy for our drug development pipelines in Neurodegeneration and Neuropsychiatry. Envisioning the future, you will work with a dedicated, cross-functional team, including regulatory, clinical development, patient reported outcomes, biomarkers and translational teams to establishing the paths for precision medicines enabled by advances in measurement. This role requires knowledge of the digital health, neuroimaging or AI diagnostics landscape, a sophisticated analytics background, and an understanding of drug development and regulatory engagement.

Key Responsibilities:

The candidate will join the Digital and AI Measures team, and establishing the Digital Health strategy for clinical phase programs, define and communicate processes for evaluating and quantifying the impact of opportunities. This will be achieved by leading internal and external talent to champion data-driven approaches to quantifying mechanism, defining patient screening and patient selection strategies, and evaluating outcomes. You will contribute to broader initiatives integrating multi-model data through AI/ML to impact target identification and precision medicine across a range of Neurodegenerative and Neuropsychiatric diseases.

The candidate's work will be tightly coupled with our Neuroscience Biomarkers, Translational Medicine, and Clinical Development teams.

• Create the strategy and process for measurement selection within clinical development programs drawing upon a combination of internal and external resources.
• Collaborate with scientists and clinicians to create measurement development plans, and with data scientists to create analysis plans to support clinical development.
• Develop and maintain relationships with external partners
• Manage introduction of a measurement technology into a clinical trial ensuring alignment among teams from clinical, technical, operations, and data science leadership to enable smooth execution in trials, and crisp execution of analyses.
• Contribute to J&J's drive towards the development of circuit driven precision medicines through advances in measurement.
• Remain current on the constantly evolving landscape of digital and imaging measures in CNS disorders.